Left Bundle Branch Block
Left Bundle Branch Block
REVIEW
ABSTRACT: Left bundle branch block may be due to conduction system degeneration or a reflection of myocardial pathology.
Left bundle branch block may also develop following aortic valve disease or cardiac procedures. Patients with heart failure
with reduced ejection fraction and left bundle branch block may respond positively to cardiac resynchronization therapy. Lead
placement via the coronary sinus is the mainstay approach of cardiac resynchronization therapy. However, other options,
including physiological pacing, are being explored. In this review, we summarize the salient pathophysiologic and clinical
aspects of left bundle branch block, as well as current and future strategies for management.
Key Words: aortic valve ◼ atrioventricular node ◼ cardiac resynchronization therapy ◼ heart failure ◼ left bundle branch block
O
ver the years, important questions regarding the septum; most of these fibers course into the left bun-
clinical implications of left bundle branch block dle branch (LBB) before continuing as the right bundle
(LBBB) with/without known cardiovascular disease branch (RBBB).2 The LBB emerges from the inferior
continue to be raised. In this review, we summarize the border of the membranous septum at the base of the
literature behind the physiology and pathogenesis of
Downloaded from http://ahajournals.org by on March 5, 2024
Correspondence to: Yong-Mei Cha, MD, Consultant, Department of Cardiovascular Medicine, Department of Medicine, Cardiac Device, Mayo Clinic, 200 1st St
Southwest Rochester, MN 55905. Email ycha@mayo.edu
For Sources of Funding and Disclosures, see page 374.
© 2020 American Heart Association, Inc.
Circulation: Arrhythmia and Electrophysiology is available at www.ahajournals.org/journal/circep
next section and in Table. through the His bundle (≈1.5 m/s) to the bundle
As discussed in further detail later, an LBBB-like pat- branches and Purkinje network.10 The fast conduction
tern can be seen in the setting of myocardial pathology. velocity is facilitated by the longitudinal arrangement of
Additionally, damage to the distributaries of the LBB can the cells and high saturation of gap junction proteins—
occur, resulting in left anterior and posterior fascicular specifically connexins 40, 43, and 45—along the longi-
blocks (left anterior fascicular block and left posterior tudinal ends.11,12 An LBBB pattern on the surface ECG
fascicular block, respectively). Whereas left anterior fas- can result from damage to the LBB itself, conduction
cicular block is relatively common in the general popula- delay within the fascicles or Purkinje fibers (to LV myo-
tion (ranging between 0.9% and 6.2% based on several cardium), or a combination of all. With LV myocardial
Figure 1. Anatomy of the cardiac conduction system and its relationship to surrounding structures.
Figure 2. Intracardiac electrogram with a concomitant right-sided His and left bundle signal.
HRA indicates high right atrium; LB, left bundle; Rvad, right ventricular apex (distal); R HIS, right-sided His.
disease, gap junction proteins (especially connexin 43) is, therefore, paramount for His bundle pacing (HBP),
are significantly rearranged and lateralized; in addition, LBB area pacing, or optimizing CRT response.16
structural remodeling may also alter cell coupling among
Downloaded from http://ahajournals.org by on March 5, 2024
Figure 3. Potential conduction blocks in the His bundle and left bundle branch (LBB).
1, Atrioventricular nodal block; 2: LBB block (LBBB); 3: left posterior fascicular block; and 4: left anterior fascicular block. Inline: ECGs of
typical LBBB (top) and LBBB-like pattern in hypertrophic cardiomyopathy (bottom). Although the QRS durations are >140 ms in both, there is
Downloaded from http://ahajournals.org by on March 5, 2024
clear mid-QRS notching in leads I and aVL for the former, whereas the QRS complexes are smooth and symmetrical in the latter.
contraction occurring within the first 70% of the systolic in association with LBBB.23 Nuclear imaging allows for the
ejection phase; and (3) early stretching wall showing peak assessment of mechanical dyssynchrony as well.21 Just as
contraction after aortic valve closure.22 In addition to high- in echocardiography, these advanced imaging techniques
lighting the mechanical consequences of conduction delay, may be helpful in distinguishing between responders and
such imaging characteristics have been helpful in predict- nonresponders of CRT therapy.23
ing patient responses to CRT.20,22
Other imaging modalities have also been successfully
utilized in the context of LBBB. Metrics for cardiac mag- Associated Genetic Factors
netic resonance imaging have been developed to quantita- Although LBBB is not generally considered a heri-
tively characterize the extent of mechanical dyssynchrony table disorder, studies have implicated several genetic
ACCF indicates American College of Cardiology Foundation; AHA, American Heart Association; HRS, Heart Rhythm Society; and LBBB, left bundle branch
block.
*≥2 leads (I, aVL, V1, V2, V5, V6).
mutations in association with bundle branch block. LBBB and cardiovascular disease,29 data from the Fram-
These mutations may involve: ion channel genes (includ- ingham study showed a significantly elevated risk of car-
ing HCN4 [hyperpolarization-activated cyclic nucleotide- diovascular deaths (50% within 10 years of onset) among
gated 4]), gap junction proteins, desmosomal genes, and individuals with LBBB.30 More recent studies have high-
cardiac transcription factors.24–26 Genetically mediated lighted LBBB as an independent predictor for adverse
bundle branch block tends to be progressive in nature, events, including sudden cardiac death (10 fold incidence
with many individuals developing complete atrioventric- increase)31as well as mortality from HF (3.08× increased
ular block or sudden cardiac death.26 risk) and myocardial infarction (2.90× increased risk),32
particularly among individuals aged 50 years and above.31
Downloaded from http://ahajournals.org by on March 5, 2024
LBBB in Association With Coronary Artery of transcatheter aortic valve replacement (TAVR)
Disease and Acute Myocardial infarction has markedly transformed the landscape of the man-
agement of aortic stenosis.44 However, conduction
Analyses of patients with LBBB and concomitant coro-
abnormalities—including LBBB and high-grade atrio-
nary artery disease (CAD) demonstrated increased risks
ventricular block requiring permanent pacemaker (PPM)
of adverse outcomes in comparison to patients with CAD
implantation—are commonly noted complications.4,45 The
but no LBBB (2.9-fold increased risk of cardiovascular
incidence of new-onset LBBB may be as high as 65%,
mortality and 1.4-fold increased risk of all-cause mortal-
ity).30,37 Similarly, among patients who underwent nuclear with the majority occurring intraprocedurally or within
exercise testing for known or suspected CAD, LBBB was 24 hours postprocedure.46 The self-expandable CoreV-
independently associated with a 50% increase in all-cause alve system (Medtronic, Minneapolis, MN) has a higher
mortality.38 Furthermore, underlying LBBB may confound observed incidence of LBBB and atrioventricular block
stress test findings, thereby affecting clinicians’ ability to compared with the Edwards SAPIEN devices (Edwards
identify obstructive CAD among these patients.39 Because Lifesciences LLC, Irvine, CA); specifically, the CoreValve
of the asynchronous activation of the interventricular sep- was associated with LBBB and PPM risks of 18% to
tum with LBBB, assessing for wall motion abnormalities 65% and 25% to 28%, respectively, compared with 4%
with echocardiography becomes more challenging, partic- to 30% and 5% to 7%, respectively, for the Edwards
ularly during tachycardia. However, its diagnostic accuracy SAPIEN valves.4,45 Procedural factors such as prosthe-
may be improved significantly with the use of myocar- sis implantation depth within the LV outflow tract47 and
dial contrast administration.40 Nuclear perfusion stud- extent of LV outflow tract stretching by balloon dilation
ies of patients with LBBB, however, have shown relative or device implantation48 are associated with increased
hypoperfusion in the interventricular septum along with risk of new-onset LBBB as well. Approximately 13% of
increased blood flow to the lateral wall; this relative septal patients with new LBBB post-TAVR have been noted to
hypoperfusion may become exaggerated during exercise, develop high-grade atrioventricular block before or after
thereby leading to false-positive interpretations of signifi- discharge.49 A recent meta-analysis also showed a 2-fold
cant CAD in the left anterior descending territory.41 When increased risk of PPM implantation among patients with
LBBB is present, 3 key findings have been suggested to new-onset post-TAVR LBBB.50 Such observances high-
correlate true ischemia (1) reversible perfusion defect(s), light the need for close electrocardiographic monitoring
especially at end-diastole; (2) concomitant apical defect,
Downloaded from http://ahajournals.org by on March 5, 2024
in HF symptoms/hospitalizations and mortality among QRS≥150 ms but not <140 ms).74,80 It should be noted
patients with LVEF<35% and QRS duration >120 that women with narrower QRS durations may respond
ms who received CRT. In a subgroup analysis of the positively to CRT as well.74 Furthermore, studies have
MADIT-CRT trial, patients with QRS duration <150 ms found that application of the Strauss criteria was help-
did not appear to derive benefit from CRT72; this rela- ful in predicting remodeling following CRT, suggesting
tionship is well visualized in data from the REVERSE its potential utility in selecting appropriate patients for
trial (Figure 5).73 Furthermore, the type of intraventricu- therapy.81
lar conduction delay may affect CRT response, where The effect of CRT on cardiovascular and mortality
LBBB but not RBBB block or nonspecific conduction outcomes on patients with less severe LV dysfunction
delay was associated with improvement in outcomes (ie, LVEF>30%–35%) remains uncertain. Substudies
following CRT.74 The Echo-CRT trial (Echocardiogra- of randomized controlled trials suggested that patients
phy Guided Cardiac Resynchronization Therapy), which with LVEF>30% to 35% may benefit from CRT.82
enrolled patients with QRS duration <130 ms and echo- Interestingly, a retrospective analysis of patients with
cardiographic evidence of mechanical dyssynchrony, LVEF of 36% to 50% found that concomitant LBBB
also showed that CRT was associated with increased was associated with poorer cardiovascular outcomes
mortality.75 As such, major US (American College of (LVEF decrease, need for implantable cardioverter-
Cardiology/AHA/HRS)76 and European Society of defibrillator implantation, and mortality).56 Thus, there is
Cardiology guidelines77,78 were consistent in issuing burgeoning literature highlighting the potential benefit
Class I and IIA recommendations for CRT in individu- of CRT among individuals with moderate degrees of LV
als with QRS>150 ms alongside LBBB and non-LBBB dysfunction and LBBB.
morphologies, respectively. In contrast, the European Special mention should be made of patients with
Society of Cardiology HF Association revised the QRS depressed LVEF who require frequent ventricular
duration cutoff for CRT to 130 ms (regardless of QRS pacing. In the BLOCK HF randomized controlled
morphology) largely due to results from Echo-CRT,79 trial (Biventricular Versus Right Ventricular Pacing in
whereas the 120 ms cutoff for CRT consideration Heart Failure Patients With Atrioventricular Block),
remained unchanged in the AHA/ACCF/HRS guide- patients in the RV paced group had higher rates of
lines. Additionally, in New York Heart Association class adverse outcomes (all-cause mortality, urgent visit
II to IV patients with HF with LBBB and QRS durations for HF, and ≥15% increase in LV end-systolic volume
between 130 and 149 ms, the European Society of index) compared with patients in the biventricular
Downloaded from http://ahajournals.org by on March 5, 2024
Cardiology HF Association offered a class I recom- paced group. 83 These results, along with data from the
mendation for CRT, differing from the class IIa recom- MOST (Mode Selection Trial in Sinus Node Dysfunc-
mendation by the AHA/ACCF/HRS; the rationale for tion) 84 and DAVID (Dual Chamber and VVI Implant-
the latter recommendation was made based on the able Defibrillator) 85 trials, contributed to the Class IIa
subgroup analyses in MADIT-CRT and RAFT (Resyn- recommendation for biventricular pacing (and Class
chronization-Defibrillation for Ambulatory Heart Fail- IIb for HBP) in patients with LVEF between 36%
ure Trial) (whereby benefits were seen in patients with and 50% who require >40% ventricular pacing per
Figure 5. The relationship between QRS duration and response to cardiac resynchronization therapy (CRT) based on data from
the REVERSE trial (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction).
Reprinted from Poole et al73 with permission. Copyright © 2016, Elsevier.
the 2018 AHA/ACCF/HRS bradycardia and con- American College of Cardiology/AHA Guideline for
duction delay guidelines.9 Finally, for patients with the Management of HF offers a class IIa recommen-
LVEF<35% and >40% ventricular pacing, the 2013 dation for CRT.76
His Bundle and LBB Area Pacing of longitudinal dissociation has not gone unchallenged;
for example, Lazzara et al87 demonstrated evidence for
Seminal light and electron microscopy studies by James
the presence of interconnecting transverse conducting
and Sherf1 provided histological evidence that conduc- fibers within the His bundle, allowing for a small residual
tion fibers within the His bundle are predestined to form intact bundle following an incision to activate the whole
the LBB and RBBB. As such, bundle branch block can bundle distal to the incision without affecting the activa-
result from a relatively proximal lesion within the His tion pattern significantly. This led to the postulation of
bundle. Subsequently, Narula et al86 was able to correct other possible mechanisms for how HBP can correct
LBBB in a series of patients by pacing the His bundle, bundle branch block, including (1) source-sink mismatch,
thereby providing powerful evidence for the longitudinal where there is insufficient voltage gradient for depolar-
dissociation of conduction fibers within the His bundle ization between proximal conducting cells (source) and
(Figure 6). Despite these supportive findings, the concept distal His-Purkinje system (sink) and an increase in
Downloaded from http://ahajournals.org by on March 5, 2024
11. Davis LM, Rodefeld ME, Green K, Beyer EC, Saffitz JE. Gap junction 30. Schneider JF, Thomas HE Jr, Kreger BE, McNamara PM, Kannel WB. Newly
protein phenotypes of the human heart and conduction system. J Car- acquired left bundle-branch block: the Framingham study. Ann Intern Med.
diovasc Electrophysiol. 1995;6(10 pt 1):813–822. doi: 10.1111/j.1540- 1979;90:303–310. doi: 10.7326/0003-4819-90-3-303
8167.1995.tb00357.x 31. Rabkin SW, Mathewson FA, Tate RB. Natural history of left bundle-branch
12. Atkinson A, Inada S, Li J, Tellez JO, Yanni J, Sleiman R, Allah EA, block. Br Heart J. 1980;43:164–169. doi: 10.1136/hrt.43.2.164
Anderson RH, Zhang H, Boyett MR, et al. Anatomical and molecular map- 32. Imanishi R, Seto S, Ichimaru S, Nakashima E, Yano K, Akahoshi M. Prog-
ping of the left and right ventricular His-Purkinje conduction networks. J Mol nostic significance of incident complete left bundle branch block observed
Cell Cardiol. 2011;51:689–701. doi: 10.1016/j.yjmcc.2011.05.020 over a 40-year period. Am J Cardiol. 2006;98:644–648. doi: 10.1016/j.
13. Rohr S. Role of gap junctions in the propagation of the cardiac action potential. amjcard.2006.03.044
Cardiovasc Res. 2004;62:309–322. doi: 10.1016/j.cardiores.2003.11.035 33. Eriksson P, Wilhelmsen L, Rosengren A. Bundle-branch block in middle-
14. Auffret V, Martins RP, Daubert C, Leclercq C, Le Breton H, Mabo P, aged men: risk of complications and death over 28 years. The primary pre-
Donal E. Idiopathic/iatrogenic left bundle branch block-induced reversible vention study in Göteborg, Sweden. Eur Heart J. 2005;26:2300–2306. doi:
left ventricle dysfunction: JACC state-of-the-art review. J Am Coll Cardiol. 10.1093/eurheartj/ehi580
2018;72:3177–3188. doi: 10.1016/j.jacc.2018.09.069 34. Littmann L, Symanski JD. Hemodynamic implications of left bundle branch
15. Auricchio A, Fantoni C, Regoli F, Carbucicchio C, Goette A, Geller C, Kloss M, block. J Electrocardiol. 2000;33(suppl):115–121. doi: 10.1054/jelc.
Klein H. Characterization of left ventricular activation in patients with heart 2000.20330
failure and left bundle-branch block. Circulation. 2004;109:1133–1139. 35. Tan NY, Witt CM, McLeod CJ, Gersh BJ. Recurrent flash pulmonary edema
doi: 10.1161/01.CIR.0000118502.91105.F6 due to rate-dependent left bundle branch block. HeartRhythm Case Rep.
16. Upadhyay GA, Cherian T, Shatz DY, Beaser AD, Aziz Z, Ozcan C, 2016;2:514–516. doi: 10.1016/j.hrcr.2016.08.005
Broman MT, Nayak HM, Tung R. Intracardiac delineation of septal conduc- 36. Shvilkin A, Ellis ER, Gervino EV, Litvak AD, Buxton AE, Josephson ME. Pain-
tion in left bundle-branch block patterns. Circulation. 2019;139:1876–1888. ful left bundle branch block syndrome: clinical and electrocardiographic
doi: 10.1161/CIRCULATIONAHA.118.038648 features and further directions for evaluation and treatment. Heart Rhythm.
17. Sciarra L, Golia P, Palamà Z, Scarà A, De Ruvo E, Borrelli A, Martino AM, 2016;13:226–232. doi: 10.1016/j.hrthm.2015.08.001
Minati M, Fagagnini A, Tota C, et al. Patients with left bundle branch block 37. Zhang ZM, Rautaharju PM, Soliman EZ, Manson JE, Cain ME, Martin LW,
and left axis deviation show a specific left ventricular asynchrony pattern: Bavry AA, Mehta L, Vitolins M, Prineas RJ. Mortality risk associated with
implications for left ventricular lead placement during CRT implantation. J bundle branch blocks and related repolarization abnormalities (from the
Electrocardiol. 2018;51:175–181. doi: 10.1016/j.jelectrocard.2017.10.006 Women’s Health Initiative [WHI]). Am J Cardiol. 2012;110:1489–1495. doi:
18. Tzogias L, Steinberg LA, Williams AJ, Morris KE, Mahlow WJ, Fogel RI, 10.1016/j.amjcard.2012.06.060
38. Hesse B, Diaz LA, Snader CE, Blackstone EH, Lauer MS. Complete
Olson JA, Prystowsky EN, Padanilam BJ. Electrocardiographic features and
bundle branch block as an independent predictor of all-cause mortality:
prevalence of bilateral bundle-branch delay. Circ Arrhythm Electrophysiol.
report of 7,073 patients referred for nuclear exercise testing. Am J Med.
2014;7:640–644. doi: 10.1161/CIRCEP.113.000999
2001;110:253–259. doi: 10.1016/s0002-9343(00)00713-0
19. Oh JK, Kane GC, Tajik AJ. The Echo Manual. Philadelphia, PA: Wolters Klu-
39. Fihn SD, Blankenship JC, Alexander KP, Bittl JA, Byrne JG, Fletcher BJ,
wer; 2018.
Fonarow GC, Lange RA, Levine GN, Maddox TM, et al. 2014 ACC/AHA/
20. Stankovic I, Prinz C, Ciarka A, Daraban AM, Kotrc M, Aarones M, Szulik M,
AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis
Winter S, Belmans A, Neskovic AN, et al. Relationship of visually assessed
and management of patients with stable ischemic heart disease: a report of
apical rocking and septal flash to response and long-term survival following
the American College of Cardiology/American Heart Association Task Force
cardiac resynchronization therapy (PREDICT-CRT). Eur Heart J Cardiovasc
Downloaded from http://ahajournals.org by on March 5, 2024
47. Urena M, Mok M, Serra V, Dumont E, Nombela-Franco L, DeLarochellière R, 65. Wang NC, Li JZ, Adelstein EC, Althouse AD, Sharbaugh MS, Jain SK,
Doyle D, Igual A, Larose E, Amat-Santos I, et al. Predictive factors and long- Mendenhall GS, Shalaby AA, Voigt AH, Saba S. New-onset left bundle
term clinical consequences of persistent left bundle branch block following branch block-associated idiopathic nonischemic cardiomyopathy and time
transcatheter aortic valve implantation with a balloon-expandable valve. J Am from diagnosis to cardiac resynchronization therapy: the NEOLITH II study.
Coll Cardiol. 2012;60:1743–1752. doi: 10.1016/j.jacc.2012.07.035 Pacing Clin Electrophysiol. 2018;41:143–154. doi: 10.1111/pace.13264
48. Hein-Rothweiler R, Jochheim D, Rizas K, Egger A, Theiss H, Bauer A, 66. Wang NC, Singh M, Adelstein EC, Jain SK, Mendenhall GS, Shalaby AA,
Massberg S, Mehilli J. Aortic annulus to left coronary distance as a predictor Voigt AH, Saba S. New-onset left bundle branch block-associated idiopathic
for persistent left bundle branch block after TAVI. Catheter Cardiovasc Interv. nonischemic cardiomyopathy and left ventricular ejection fraction response
2017;89:E162–E168. doi: 10.1002/ccd.26503 to guideline-directed therapies: the NEOLITH study. Heart Rhythm.
49. Toggweiler S, Stortecky S, Holy E, Zuk K, Cuculi F, Nietlispach F, Sabti Z, 2016;13:933–942. doi: 10.1016/j.hrthm.2015.12.020
Suciu R, Maier W, Jamshidi P, et al. The electrocardiogram after transcath- 67. Virtanen KS, Heikkilä J, Kala R, Siltanen P. Chest pain and rate-dependent
eter aortic valve replacement determines the risk for post-procedural high- left bundle branch block in patients with normal coronary arteriograms.
degree AV block and the need for telemetry monitoring. JACC Cardiovasc Chest. 1982;81:326–331. doi: 10.1378/chest.81.3.326
Interv. 2016;9:1269–1276. doi: 10.1016/j.jcin.2016.03.024 68. Suryanarayana PG, Frankel DS, Marchlinski FE, Schaller RD. Painful
50. Regueiro A, Abdul-Jawad Altisent O, Del Trigo M, Campelo-Parada F, left bundle branch block syndrome treated successfully with perma-
Puri R, Urena M, Philippon F, Rodés-Cabau J. Impact of new-onset left nent His bundle pacing [published correction appears in HeartRhythm
bundle branch block and periprocedural permanent pacemaker implanta- Case Rep. 2018;4:608]. HeartRhythm Case Rep. 2018;4:439–443. doi:
tion on clinical outcomes in patients undergoing transcatheter aortic valve 10.1016/j.hrcr.2018.08.005
replacement: a systematic review and meta-analysis. Circ Cardiovasc Interv. 69. Sze E, Samad Z, Dunning A, Campbell KB, Loring Z, Atwater BD, Chiswell K,
2016;9:e003635. doi: 10.1161/CIRCINTERVENTIONS.115.003635 Kisslo JA, Velazquez EJ, Daubert JP. Impaired recovery of left ventricular
51. Khounlaboud M, Flécher E, Fournet M, Le Breton H, Donal E, Leclercq C, function in patients with cardiomyopathy and left bundle branch block. J Am
Mabo P, Leguerrier A, Daubert C. Predictors and prognostic impact of new Coll Cardiol. 2018;71:306–317. doi: 10.1016/j.jacc.2017.11.020
left bundle branch block after surgical aortic valve replacement. Arch Car- 70. Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, Cazeau S, McKenna W,
diovasc Dis. 2017;110:667–675. doi: 10.1016/j.acvd.2017.03.007 Fitzgerald M, Deharo JC, Alonso C, et al. Long-term benefits of biventricular
52. Nishimura RA, Seggewiss H, Schaff HV. Hypertrophic obstructive cardio- pacing in congestive heart failure: results from the MUltisite STimulation in
myopathy: surgical myectomy and septal ablation. Circ Res. 2017;121:771– cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111–118. doi:
783. doi: 10.1161/CIRCRESAHA.116.309348 10.1016/s0735-1097(02)01932-0
53. Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G,
71. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T,
Kaple RK, Dolney DO, Blackstone EH. Current effectiveness and risks of
Carson P, DiCarlo L, DeMets D, White BG, et al; Comparison of Medical Ther-
isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Ann
apy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators.
Thorac Surg. 2008;85:127–133. doi: 10.1016/j.athoracsur.2007.07.063
Cardiac-resynchronization therapy with or without an implantable defibrilla-
54. Kotkar KD, Said SM, Dearani JA, Schaff HV. Hypertrophic obstruc-
tor in advanced chronic heart failure. N Engl J Med. 2004;350:2140–2150.
tive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg.
doi: 10.1056/NEJMoa032423
2017;6:329–336. doi: 10.21037/acs.2017.07.03
72. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA III,
55. Baldasseroni S, Opasich C, Gorini M, Lucci D, Marchionni N, Marini
Foster E, Greenberg H, Higgins SL, et al; MADIT-CRT Trial Investigators.
M, Campana C, Perini G, Deorsola A, Masotti G, et al; Italian Network on
Cardiac-resynchronization therapy for the prevention of heart-failure events.
Congestive Heart Failure Investigators. Left bundle-branch block is asso-
N Engl J Med. 2009;361:1329–1338. doi: 10.1056/NEJMoa0906431
Downloaded from http://ahajournals.org by on March 5, 2024
ciated with increased 1-year sudden and total mortality rate in 5517
73. Poole JE, Singh JP, Birgersdotter-Green U. QRS duration or QRS morphol-
outpatients with congestive heart failure: a report from the Italian Net-
ogy: what really matters in cardiac resynchronization therapy? J Am Coll
work on Congestive Heart Failure. Am Heart J. 2002;143:398–405. doi:
Cardiol. 2016;67:1104–1117. doi: 10.1016/j.jacc.2015.12.039
10.1067/mhj.2002.121264
74. Zareba W, Klein H, Cygankiewicz I, Hall WJ, McNitt S, Brown M,
56. Witt CM, Wu G, Yang D, Hodge DO, Roger VL, Cha YM. Outcomes with left
Cannom D, Daubert JP, Eldar M, Gold MR, et al; MADIT-CRT Investigators.
bundle branch block and mildly to moderately reduced left ventricular func-
Effectiveness of cardiac resynchronization therapy by QRS morphology in
tion. JACC Heart Fail. 2016;4:897–903. doi: 10.1016/j.jchf.2016.07.002
the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resyn-
57. Mazur A, Kusniec J, Strasberg B. Bundle branch reentrant ventricular tachy-
cardia. Indian Pacing Electrophysiol J. 2005;5:86–95. chronization Therapy (MADIT-CRT). Circulation. 2011;123:1061–1072. doi:
58. Balasundaram R, Rao HB, Kalavakolanu S, Narasimhan C. Catheter ablation 10.1161/CIRCULATIONAHA.110.960898
of bundle branch reentrant ventricular tachycardia. Heart Rhythm. 2008;5(6 75. Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J,
suppl):S68–S72. doi: 10.1016/j.hrthm.2008.02.036 Dickstein K, Ford I, Gorcsan J III, Gras D, et al; EchoCRT Study Group. Car-
59. Blanck Z, Akhtar M. Ventricular tachycardia due to sustained bundle diac-resynchronization therapy in heart failure with a narrow QRS complex.
branch reentry: diagnostic and therapeutic considerations. Clin Cardiol. N Engl J Med. 2013;369:1395–1405. doi: 10.1056/NEJMoa1306687
1993;16:619–622. doi: 10.1002/clc.4960160812 76. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH,
60. Roberts JD, Gollob MH, Young C, Connors SP, Gray C, Wilton SB, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, et al. 2013 ACCF/AHA
Green MS, Zhu DW, Hodgkinson KA, Poon A, et al. Bundle branch re- guideline for the management of heart failure: executive summary: a report
entrant ventricular tachycardia: novel genetic mechanisms in a life- of the American College of Cardiology Foundation/American Heart Associ-
threatening arrhythmia. JACC Clin Electrophysiol. 2017;3:276–288. doi: ation Task Force on practice guidelines. Circulation. 2013;128:1810–1852.
10.1016/j.jacep.2016.09.019 doi: 10.1161/CIR.0b013e31829e8807
61. Schmidt B, Tang M, Chun KR, Antz M, Tilz RR, Metzner A, Koektuerk B, 77. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G,
Xie P, Kuck KH, Ouyang F. Left bundle branch-Purkinje system in patients Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, et al; European
with bundle branch reentrant tachycardia: lessons from catheter abla- Society of Cardiology; European Heart Rhythm Association. 2013 ESC
tion and electroanatomic mapping. Heart Rhythm. 2009;6:51–58. doi: guidelines on cardiac pacing and cardiac resynchronization therapy: the
10.1016/j.hrthm.2008.09.028 task force on cardiac pacing and resynchronization therapy of the European
62. Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Society of Cardiology (ESC). Developed in collaboration with the European
Prinzen FW. Left bundle branch block induces ventricular remodelling Heart Rhythm Association (EHRA). Europace. 2013;15:1070–1118. doi:
and functional septal hypoperfusion. Eur Heart J. 2005;26:91–98. doi: 10.1093/europace/eut206
10.1093/eurheartj/ehi008 78. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS,
63. Vaillant C, Martins RP, Donal E, Leclercq C, Thébault C, Behar N, Mabo P, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, et al; ESC Sci-
Daubert JC. Resolution of left bundle branch block-induced cardiomyopa- entific Document Group. 2016 ESC Guidelines for the diagnosis and treat-
thy by cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61:1089– ment of acute and chronic heart failure: the task force for the diagnosis
1095. doi: 10.1016/j.jacc.2012.10.053 and treatment of acute and chronic heart failure of the European Society
64. Sze E, Daubert JP. Left bundle branch block-induced left ventricular remod- of Cardiology (ESC) developed with the special contribution of the Heart
eling and its potential for reverse remodeling. J Interv Card Electrophysiol. Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
2018;52:343–352. doi: 10.1007/s10840-018-0407-2 doi: 10.1093/eurheartj/ehw128
79. Normand C, Linde C, Singh J, Dickstein K. Indications for cardiac resynchro- ACC’s Electrophysiology Council. His bundle pacing. J Am Coll Cardiol.
nization therapy: a comparison of the major international guidelines. JACC 2018;72:927–947. doi: 10.1016/j.jacc.2018.06.017
Heart Fail. 2018;6:308–316. doi: 10.1016/j.jchf.2018.01.022 90. Upadhyay GA, Tung R. Selective versus non-selective His bundle pacing for
80. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, cardiac resynchronization therapy. J Electrocardiol. 2017;50:191–194. doi:
Hohnloser SH, Nichol G, Birnie DH, Sapp JL, et al; Resynchronization- 10.1016/j.jelectrocard.2016.10.003
Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac- 91. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent,
resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. direct His-bundle pacing: a novel approach to cardiac pacing in patients
2010;363:2385–2395. doi: 10.1056/NEJMoa1009540 with normal His-Purkinje activation. Circulation. 2000;101:869–877. doi:
81. Emerek K, Risum N, Hjortshøj S, Riahi S, Rasmussen JG, Bloch Thomsen PE, 10.1161/01.cir.101.8.869
Graff C, Søgaard P. New strict left bundle branch block criteria reflect left 92. Zanon F, Ellenbogen KA, Dandamudi G, Sharma PS, Huang W,
ventricular activation differences. J Electrocardiol. 2015;48:758–762. doi: Lustgarten DL, Tung R, Tada H, Koneru JN, Bergemann T, et al. Permanent
10.1016/j.jelectrocard.2015.07.008 His-bundle pacing: a systematic literature review and meta-analysis. Euro-
82. Hai OY, Mentz RJ, Zannad F, Gasparini M, De Ferrari GM, Daubert JC, pace. 2018;20:1819–1826. doi: 10.1093/europace/euy058
Holzmeister J, Lam CS, Pochet T, Vincent A, et al. Cardiac resynchronization 93. Arnold AD, Shun-Shin MJ, Keene D, Howard JP, Sohaib SMA,
therapy in heart failure patients with less severe left ventricular dysfunction. Wright IJ, Cole GD, Qureshi NA, Lefroy DC, Koa-Wing M, et al. His resyn-
Eur J Heart Fail. 2015;17:135–143. doi: 10.1002/ejhf.208 chronization versus biventricular pacing in patients with heart failure and
83. Curtis AB, Worley SJ, Adamson PB, Chung ES, Niazi I, Sherfesee L, Shinn T,
left bundle branch block. J Am Coll Cardiol. 2018;72:3112–3122. doi:
Sutton MS; Biventricular versus Right Ventricular Pacing in Heart Failure
10.1016/j.jacc.2018.09.073
Patients with Atrioventricular Block (BLOCK HF) Trial Investigators. Biven-
94. Upadhyay GA, Vijayaraman P, Nayak HM, Verma N, Dandamudi G,
tricular pacing for atrioventricular block and systolic dysfunction. N Engl J
Sharma PS, Saleem M, Mandrola J, Genovese D, Tung R; His-SYNC Inves-
Med. 2013;368:1585–1593. doi: 10.1056/NEJMoa1210356
tigators. His corrective pacing or biventricular pacing for cardiac resyn-
84. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA,
chronization in heart failure. J Am Coll Cardiol. 2019;74:157–159. doi:
Flaker G, Schron E, Orav EJ, et al; Mode Selection Trial in Sinus-Node Dys-
10.1016/j.jacc.2019.04.026
function. Ventricular pacing or dual-chamber pacing for sinus-node dysfunc-
95. Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. A novel pacing
tion. N Engl J Med. 2002;346:1854–1862. doi: 10.1056/NEJMoa013040
strategy with low and stable output: pacing the left bundle branch immedi-
85. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP,
Sharma A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. ately beyond the conduction block. Can J Cardiol. 2017;33:1736.e1–1736.
Dual-chamber pacing or ventricular backup pacing in patients with an implant- e3. doi: 10.1016/j.cjca.2017.09.013
able defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) 96. Boink GJ, Duan L, Nearing BD, Shlapakova IN, Sosunov EA, Anyukhovsky
trial. JAMA. 2002;288:3115–3123. doi: 10.1001/jama.288.24.3115 EP, Bobkov E, Kryukova Y, Ozgen N, Danilo P Jr, et al. HCN2/SkM1 gene
86. Narula OS. Longitudinal dissociation in the His bundle. Bundle branch block transfer into canine left bundle branch induces stable, autonomically
due to asynchronous conduction within the His bundle in man. Circulation. responsive biological pacing at physiological heart rates. J Am Coll Cardiol.
1977;56:996–1006. doi: 10.1161/01.cir.56.6.996 2013;61:1192–1201. doi: 10.1016/j.jacc.2012.12.031
87. Lazzara R, Yeh BK, Samet P. Functional transverse interconnections within 97. Takahashi T, Nagai T, Kanda M, Liu ML, Kondo N, Naito AT, Ogura T,
the His bundle and the bundle branches. Circ Res. 1973;32:509–515. doi: Nakaya H, Lee JK, Komuro I, et al. Regeneration of the cardiac conduction
10.1161/01.res.32.4.509 system by adipose tissue-derived stem cells. Circ J. 2015;79:2703–2712.
88. Sharma PS, Huizar J, Ellenbogen KA, Tan AY. Recruitment of bundle doi: 10.1253/circj.CJ-15-0400
branches with permanent His bundle pacing in a patient with advanced 98. Baheiraei N, Yeganeh H, Ai J, Gharibi R, Ebrahimi-Barough S, Azami M,
Downloaded from http://ahajournals.org by on March 5, 2024
conduction system disease: what is the mechanism? Heart Rhythm. Vahdat S, Baharvand H. Preparation of a porous conductive scaffold
2016;13:623–625. doi: 10.1016/j.hrthm.2015.11.012 from aniline pentamer-modified polyurethane/PCL blend for cardiac
89. Vijayaraman P, Chung MK, Dandamudi G, Upadhyay GA, Krishnan K, tissue engineering. J Biomed Mater Res A. 2015;103:3179–3187. doi:
Crossley G, Bova Campbell K, Lee BK, Refaat MM, Saksena S, et al; 10.1002/jbm.a.35447